Market Estimates on Global Neuroendovascular Coil and Non-Coil Devices - (2016 - 2021)

Global Neuroendovascular Coil and Non-Coil Devices Market-Growth, Trends and Forecasts (2016 - 2021) ​is a new market research publication announced by Reportstack. The global neuroendovascular coil and non-coil devices market is estimated at US$ XX Billion in 2016 and projected to reach US$ XX Billion by 2021, growing at a CAGR of XX% during the forecast period.

Cerebrovascular diseases include some of the most common and devastating disorders: ischemic stroke and hemorrhagic stroke. According to the World Health Organization, 15 Million people suffer stroke worldwide each year. Of these, 5 Million die and another 5 Million are permanently disabled. Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. The incidence of cerebrovascular diseases increases with age, and the number of strokes is projected to increase as the elderly population grows, with a doubling in stroke deaths in the United States by 2030.

To view the table of contents and know more details please visit Global Neuroendovascular Coil and Non-Coil Devices Market-Growth, Trends and Forecasts (2016 - 2021)

Drivers & Restraints

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neuroendovascular devices and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neuroendovascular coil & non-coil devices market.

Device Insights

Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neuroendovascular coil & non-coil devices market with XX% market share by the end of 2021.

Country Insights

United States is seen as the dominant player in the neuroendovascular coil & non-coil devices market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

Market Segmentation

Based on Device

• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter

Based on Disease

Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation(AVM)

Based on Geography

• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil

Based on Company

• Stryker
• Medtronic
• MicroVention (Terumo Corporation)
• De Puy Synthes

Companies Mentioned

Stryker,Medtronic,Terumo Corporation,DePuy Synthes

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###